We have previously discussed the role of NOS in cancer progression and metastases and as a therapeutic target in multiple tumor types, including melanoma, hepatocellular carcinoma, pancreatic ductal adenocarcinoma, head and neck squamous carcinomas, and glioblastomas36. This evidence concerns the gene NOS2 and cancer.